Sangamo Biosciences reported $14.5M in Selling and Administration Expenses for its third fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Selling And Administration Expenses Change
Acceleron Pharma XLRN:US $ 45.11M 9.64M
Alnylam Pharmaceuticals ALNY:US $ 142.07M 11.75M
Amgen AMGN:US $ 1.31B 79M
Avrobio Inc AVRO:US 9.58M 746K
Bayer BAYN:GR 3.77B 19M
Biocryst Pharmaceuticals BCRX:US $ 34.99M 8.67M
Biogen BIIB:US $ 654.1M 16.8M
Biomarin Pharmaceutical BMRN:US $ 183.33M 828K
Bluebird Bio BLUE:US $ 68.28M 10.3M
Gilead Sciences GILD:US $ 1.18B 173M
GlaxoSmithKline GSK:LN 2.5B 6M
Intercept Pharmaceuticals ICPT:US $ 53.34M 4.32M
IONIS PHARMACEUT IONS:US $ 31M 25.46M
Johnson & Johnson JNJ:US $ 6B 73M
Karyopharm Therapeutics KPTI:US $ 35.1M 1.43M
Merk MRK:US $ 2.27B 9M
Novartis NOVN:VX 3.6B 109M
Omeros OMER:US $ 20.86M 699K
Pfizer PFE:US $ 2.73B 61M
Regulus Therapeutics RGLS:US $ 2.5M 16K
Sangamo Biosciences SGMO:US $ 14.5M 1.98M
Sarepta Therapeutics SRPT:US $ 61.13M 11.22M
Ultragenyx Pharmaceutical RARE:US $ 53.88M 473K
Vertex Pharmaceuticals VRTX:US $ 198.19M 3.52M
Ziopharm Oncology ZIOP:US $ 8.17M 896K